114 related articles for article (PubMed ID: 38228470)
1. Development of a novel quality by design-enabled stability-indicating HPLC method and its validation for the quantification of nirmatrelvir in bulk and pharmaceutical dosage forms.
Alegete P; Byreddy S
Biomed Chromatogr; 2024 Mar; 38(3):e5812. PubMed ID: 38228470
[TBL] [Abstract][Full Text] [Related]
2. Development of a validated liquid chromatographic method for quantification of sorafenib tosylate in the presence of stress-induced degradation products and in biological matrix employing analytical quality by design approach.
Sharma T; Khurana RK; Jain A; Katare OP; Singh B
Biomed Chromatogr; 2018 May; 32(5):e4169. PubMed ID: 29244215
[TBL] [Abstract][Full Text] [Related]
3. A validated stability-indicating reversed-phase-HPLC method for dipyridamole in the presence of degradation products and its process-related impurities in pharmaceutical dosage forms.
Mallavarapu R; Katari NK; Dongala T; Rekulapally VK; Marisetti VM; Vyas G
Biomed Chromatogr; 2022 Jan; 36(1):e5247. PubMed ID: 34541698
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a Stability-Indicating Liquid Chromatographic Method for Estimating Olmesartan Medoxomil Using Quality by Design.
Beg S; Sharma G; Katare OP; Lohan S; Singh B
J Chromatogr Sci; 2015 Aug; 53(7):1048-59. PubMed ID: 25583970
[TBL] [Abstract][Full Text] [Related]
5. QbD-Based Stability-Indicating RP-HPLC Method Development and Validation for the Estimation of Favipiravir-An Eco-Friendly Approach.
Chandana M S; K S; A A; Narendra P; K S
J AOAC Int; 2024 May; 107(3):377-386. PubMed ID: 38318977
[TBL] [Abstract][Full Text] [Related]
6. QbD-Based Development and Validation of a Stability-Indicating HPLC Method for Estimating Ketoprofen in Bulk Drug and Proniosomal Vesicular System.
Yadav NK; Raghuvanshi A; Sharma G; Beg S; Katare OP; Nanda S
J Chromatogr Sci; 2016 Mar; 54(3):377-89. PubMed ID: 26514627
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of apalutamide-related substances method in solid dosage forms using HPLC.
Bandaru LGR; Konduru N; Kowtharapu LP; Regulagadda S; Kanuparthy PR; Gundla R
Biomed Chromatogr; 2023 Apr; 37(4):e5576. PubMed ID: 36573285
[TBL] [Abstract][Full Text] [Related]
8. Favipiravir (SARS-CoV-2) degradation impurities: Identification and route of degradation mechanism in the finished solid dosage form using LC/LC-MS method.
Vemuri DK; Gundla R; Konduru N; Mallavarapu R; Katari NK
Biomed Chromatogr; 2022 Jun; 36(6):e5363. PubMed ID: 35292997
[TBL] [Abstract][Full Text] [Related]
9. A simple and rapid HPLC method for determination of parabens and their degradation products in pharmaceutical dosage forms.
Katakam LNR; Ettaboina SK; Dongala T
Biomed Chromatogr; 2021 Oct; 35(10):e5152. PubMed ID: 33931875
[TBL] [Abstract][Full Text] [Related]
10. Quantification of Drospirenone- and Ethinyl Estradiol-Related Impurities in a Combined Pharmaceutical Dosage Form by a Chromatography Method With a QbD Robustness Study.
Chinta SR; Chintala V; Nandimalla V; Ch R; Ediga SG; Kowtharapu LP; Katari NK
J AOAC Int; 2024 Jan; 107(1):31-39. PubMed ID: 37758265
[TBL] [Abstract][Full Text] [Related]
11. Stability indicating reversed-phase-high-performance liquid chromatography method development and validation for pyridostigmine bromide and sodium benzoate in oral solution.
Chintala V
Biomed Chromatogr; 2024 Mar; 38(3):e5800. PubMed ID: 38081595
[TBL] [Abstract][Full Text] [Related]
12. STABILITY-INDICATING HPLC METHOD FOR DETERMINATION OF VANCOMYCIN HYDROCHLORIDE IN THE PHARMACEUTICAL DOSAGE FORMS.
Serri A; Moghimp HR; Mahboubi A; Zarghi A
Acta Pol Pharm; 2017 Jan; 74(1):73-79. PubMed ID: 29474763
[TBL] [Abstract][Full Text] [Related]
13. Determination of nelfinavir mesylate as bulk drug and in pharmaceutical dosage form by stability indicating HPLC.
Jing Q; Shen Y; Tang Y; Ren F; Yu X; Hou Z
J Pharm Biomed Anal; 2006 Jun; 41(3):1065-9. PubMed ID: 16545536
[TBL] [Abstract][Full Text] [Related]
14. Stability-indicating HPLC method development and validation of rivaroxaban impurities and identification of forced degradation products using LC-MS/MS.
Cholleti V; Ravindra Kumar Y; Pasula A; Surya PRP
Biomed Chromatogr; 2022 Sep; 36(9):e5424. PubMed ID: 35697473
[TBL] [Abstract][Full Text] [Related]
15. Quantification and Validation of Stability-Indicating RP-HPLC Method for Efavirenz in Bulk and Tablet Dosage Form using Quality by Design (QbD): A Shifting Paradigm.
Gurumukhi VC; Bari SB
J Chromatogr Sci; 2022 Feb; 60(2):143-156. PubMed ID: 34021559
[TBL] [Abstract][Full Text] [Related]
16. Systematic Development and Validation of a RP-HPLC Method for Estimation of Abiraterone Acetate and its Degradation Products.
Beg S; Malik AK; Afzal O; Altamimi ASA; Kazmi I; Al-Abbasi FA; Almalki WH; Barkat MA; Kawish SM; Pradhan DP; Rahman M
J Chromatogr Sci; 2021 Jan; 59(1):79-87. PubMed ID: 33169159
[TBL] [Abstract][Full Text] [Related]
17. Stability-indicating HPLC method development and validation for simultaneous estimation of metformin, dapagliflozin, and saxagliptin in bulk drug and pharmaceutical dosage form.
Vankalapati KR; Alegete P; Boodida S
Biomed Chromatogr; 2022 Jul; 36(7):e5384. PubMed ID: 35434817
[TBL] [Abstract][Full Text] [Related]
18. Determination of progesterone (steroid drug) in the semi-solid dosage form (vaginal gel) using a stability-indicating method by RP-HPLC/PDA detector.
Konduru N; Kethe VB; Gundla R; Katari NK; Mallavarapu R
Biomed Chromatogr; 2022 Jan; 36(1):e5246. PubMed ID: 34523747
[TBL] [Abstract][Full Text] [Related]
19. Stability kinetics of fusidic acid: Development and validation of stability indicating analytical method by employing Analytical Quality by Design approach in medicinal product(s).
Sharma G; Thakur K; Raza K; Katare OP
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1120():113-124. PubMed ID: 31082718
[TBL] [Abstract][Full Text] [Related]
20. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
Lalitha Devi M; Chandrasekhar KB
J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
